PLX PHARMA INC - COM (PLXPQ)

CUSIP: 72942A107

Q3 2019 13F Holders as of 30 Sep 2019

Type / Class
Equity / COM
Total 13F shares
1,969,424
Share change
+37,816
Total reported value
$10,043,000
Price per share
$5.10
Number of holders
14
Value change
-$58,984
Number of buys
6
Number of sells
9

Quarterly Holders Quick Answers

What is CUSIP 72942A107?
CUSIP 72942A107 identifies PLXPQ - PLX PHARMA INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PLX PHARMA INC - COM (PLXPQ) as of Q3 2019

As of 30 Sep 2019, PLX PHARMA INC - COM (PLXPQ) was held by 14 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,969,424 shares. The largest 10 holders included Park West Asset Management LLC, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, MILLENNIUM MANAGEMENT LLC, Heritage Way Advisors, LLC, Fayez Sarofim & Co, NORTHERN TRUST CORP, BlackRock Inc., Cranbrook Wealth Management, LLC, and WELLS FARGO & COMPANY/MN. This page lists 14 institutional shareholders reporting positions in this security for the Q3 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.